Patent · US Active

Oral solid cannabinoid formulations, methods for producing and using thereof

US11654111B2 · kind B2 · utility

0Cited by

4References

21Claims

0Family size

Assignees

SATIPHARM AG · CH
GELPELL AG · CH

Inventors

Hagit Sacks · Lod, IL
Tomas Edvinsson · Uppsala, SE

Key dates

Filing date	Dec 20, 2019
Grant date	May 23, 2023
Priority date	—
Expiry date	Dec 20, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are solid oral/per os formulations that include a single cannabinoid, combination of cannabinoids, cannabis extract and combination of cannabis plant constituents. Also provided are methods of making the formulations, as well as therapeutic applications in the treatment and alleviation of various human disorders and/or conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.